Effect of some antipsychotic drugs on immunoreactivity in C57BL/6 mice. 2002

Agnieszka Basta-Kaim, and Marta Kubera, and Bogusława Budziszewska, and Joanna Siwanowicz, and Władysław Lasoń
Department of Endocrinology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, PL, 31-343 Kraków, Poland.

The study examined the effect of some typical and atypical antipsychotic drugs on mouse lymphocyte metabolic and proliferative activity in vitro. The typical antipsychotic drug chlorpromazine (3 x 10(-6), 10(-5) and 10(-4) M), significantly inhibited 3H-thymidine incorporation into C57BL/6 mouse spleen cells stimulated by concanavalin A (Con A), lipopolysaccharide (LPS) or pokeweed mitogen (PWM). Chlorpromazine at concentrations of 10(-5) and 10(-4) M also suppressed the metabolic activity of splenocytes after Con A stimulation. The atypical antipsychotic agent clozapine (10(-4) and 10(-5) M) decreased the proliferative activity of splenocytes after LPS stimulation, but its inhibitory effect after Con A was observed only at higher concentrations. On the other hand, clozapine did not affect the metabolic activity of splenocytes. Sulpiride, a selective dopamine D2 antagonist, at concentrations ranging from 10(-8) to 10(-4) M had no inhibitory effect on the proliferative or metabolic activity of the tested cells. The obtained results indicate that of the three antipsychotic drugs studied, chlorpromazine shows the most potent immunosuppressive effect, clozapine produces a moderate effect and sulpiride is totally inactive. These findings suggest that the choice of antipsychotic drugs should also depend on disturbance of immune system activity, in particular, those occurring in the several forms of psychosis.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Agnieszka Basta-Kaim, and Marta Kubera, and Bogusława Budziszewska, and Joanna Siwanowicz, and Władysław Lasoń
September 2019, Behavioural pharmacology,
Agnieszka Basta-Kaim, and Marta Kubera, and Bogusława Budziszewska, and Joanna Siwanowicz, and Władysław Lasoń
July 2020, Pharmacology, biochemistry, and behavior,
Agnieszka Basta-Kaim, and Marta Kubera, and Bogusława Budziszewska, and Joanna Siwanowicz, and Władysław Lasoń
January 2013, International journal of body composition research,
Agnieszka Basta-Kaim, and Marta Kubera, and Bogusława Budziszewska, and Joanna Siwanowicz, and Władysław Lasoń
January 2011, Frontiers in behavioral neuroscience,
Agnieszka Basta-Kaim, and Marta Kubera, and Bogusława Budziszewska, and Joanna Siwanowicz, and Władysław Lasoń
February 1985, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Agnieszka Basta-Kaim, and Marta Kubera, and Bogusława Budziszewska, and Joanna Siwanowicz, and Władysław Lasoń
June 2017, Neuroreport,
Agnieszka Basta-Kaim, and Marta Kubera, and Bogusława Budziszewska, and Joanna Siwanowicz, and Władysław Lasoń
October 2007, Neuroscience letters,
Agnieszka Basta-Kaim, and Marta Kubera, and Bogusława Budziszewska, and Joanna Siwanowicz, and Władysław Lasoń
January 2022, Biosensors,
Agnieszka Basta-Kaim, and Marta Kubera, and Bogusława Budziszewska, and Joanna Siwanowicz, and Władysław Lasoń
January 2005, Dermatology (Basel, Switzerland),
Agnieszka Basta-Kaim, and Marta Kubera, and Bogusława Budziszewska, and Joanna Siwanowicz, and Władysław Lasoń
December 2017, Psychopharmacology,
Copied contents to your clipboard!